Irish 'Lipitor' litigation: High Court favours broad claim construction

In its first significant judgment on claim construction in over25 years, Ireland's High Court approved the principles laiddown by the English House of Lords in Kirin-Amgen, holding thatWarner-Lambert's ‘Lipitor’ patent is not limitedto a racemic mixture and refusing Ranbaxy a declaration of non-infringement.